Page last updated: 2024-08-24

ibandronic acid and Conus Medullaris Syndrome

ibandronic acid has been researched along with Conus Medullaris Syndrome in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Curtis, D; Lu, Y; Qiao, D; Wang, Z; Wen, X; Yao, Y; Zhao, H1
Boewer, C; Delmas, PD; Euller-Ziegler, L; Facon, T; Fiere, D; Fontana, A; Herrmann, Z; Hrubisko, M; Lichinitser, MR; Menssen, HD; Sakalová, A; Singer, CR; Thiel, E; Wetterwald, M1

Reviews

1 review(s) available for ibandronic acid and Conus Medullaris Syndrome

ArticleYear
Systematic literature review and network meta-analysis comparing bone-targeted agents for the prevention of skeletal-related events in cancer patients with bone metastasis.
    The oncologist, 2015, Volume: 20, Issue:4

    Topics: Bone Density Conservation Agents; Bone Diseases; Bone Neoplasms; Denosumab; Diphosphonates; Humans; Ibandronic Acid; Imidazoles; Neoplasms; Pamidronate; Spinal Cord Compression; Treatment Outcome; Zoledronic Acid

2015

Trials

1 trial(s) available for ibandronic acid and Conus Medullaris Syndrome

ArticleYear
Effects of long-term intravenous ibandronate therapy on skeletal-related events, survival, and bone resorption markers in patients with advanced multiple myeloma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, May-01, Volume: 20, Issue:9

    Topics: Bone Resorption; Chi-Square Distribution; Diphosphonates; Double-Blind Method; Female; Fractures, Bone; Humans; Hypercalcemia; Ibandronic Acid; Injections, Intravenous; Male; Middle Aged; Multiple Myeloma; Pain; Spinal Cord Compression; Survival Analysis; Treatment Outcome

2002